Mighty Therapeutics Raises Up to $150 Million for Innovative Mitochondrial Medicines Development#USA#Needham#Elamipretide#K2_HealthVentures#Mighty_Therapeutics
Mighty Therapeutics Raises Up to $150 Million for Innovative Mitochondrial Medicines Development
Mighty Therapeutics has secured up to $150 million in financing to advance its novel mitochondrial-targeted therapies, addressing major health challenges.
third-news.com
July 14, 2026 at 12:34 PM
Mighty Therapeutics Raises Up to $150 Million for Innovative Mitochondrial Medicines Development#USA#Needham#Elamipretide#K2_HealthVentures#Mighty_Therapeutics
Phil Enhances Its AI Capabilities with $60 Million from K2 HealthVentures#USA#San_Francisco#AI_Integration#Phil#K2_HealthVentures
Phil Enhances Its AI Capabilities with $60 Million from K2 HealthVentures
Phil secures $60 million funding from K2 HealthVentures to boost AI integration, accelerating its innovative pharmaceutical platform and patient access.
third-news.com
July 8, 2025 at 12:39 PM
Phil Enhances Its AI Capabilities with $60 Million from K2 HealthVentures#USA#San_Francisco#AI_Integration#Phil#K2_HealthVentures